Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2026-02-20 @ 6:05 PM
Study NCT ID:
NCT03779334
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-26
First Post:
2018-12-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Risdiplam in Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2018-12-17
First Submit QC Date:
None
Study First Post Date:
2018-12-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-02-09
Results First Submit QC Date:
None
Results First Post Date:
2024-03-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-20
Last Update Post Date:
2025-11-26
Last Update Post Date Type:
ESTIMATED